Artwork

Content provided by FierceBiotech Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by FierceBiotech Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The burning hole in Gilead's $25B pocket and AbbVie's future in hematology

19:52
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on August 03, 2019 01:33 (4+ y ago). Last successful fetch was on April 08, 2019 16:33 (5y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 121643356 series 109559
Content provided by FierceBiotech Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by FierceBiotech Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Fierce editors discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Plus, a look back at AbbVie's blockbuster buyout of Pharmacyclics and a thoughtful consideration of how a certain biotech entrepreneur is bringing attention to an FDA loophole.

  continue reading

43 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on August 03, 2019 01:33 (4+ y ago). Last successful fetch was on April 08, 2019 16:33 (5y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 121643356 series 109559
Content provided by FierceBiotech Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by FierceBiotech Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Fierce editors discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Plus, a look back at AbbVie's blockbuster buyout of Pharmacyclics and a thoughtful consideration of how a certain biotech entrepreneur is bringing attention to an FDA loophole.

  continue reading

43 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide